Abstract

Rights

Copyright: © 2020 Janiaud P et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite as

Janiaud, P., Axfors, C., Van't Hooft, J., Saccilotto, R., Agarwal, A., Appenzeller-Herzog, C., Contopoulos-Ioannidis, D., Danchev, V., Dirnagl, U., Ewald, H., Gartlehner, G., Goodman, S., Haber, N., Ioannidis, A., Ioannidis, J., Lythgoe, M., Ma, W., MacLeod, M., Malički, M., Meerpohl, J., Min, Y., Moher, D., Nagavci, B., Naudet, F., Pauli-Magnus, C., O'Sullivan, J., Riedel, N., Roth, J., Sauermann, M., Schandelmaier, S., Schmitt, A., Speich, B., Williamson, P. & Hemkens, L. 2020, 'The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days', F1000 Research, 9(1193). https://doi.org/10.12688/f1000research.26707.1

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 27 October 2022
Was this page helpful?